Article Details
Retrieved on: 2021-06-14 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The iTeos deal is to develop EOS-448, a monoclonal antibody that acts as an ... The deal with iTeos will make GSK the only company with antibodies ...
Article found on: www.pharmalive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here